Research Topics
Species | E HollanderSummaryAffiliation: Mount Sinai School of Medicine Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Obsessive compulsive disorder comorbidity in DBAStefano Pallanti
Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
Clin Pract Epidemiol Ment Health 4:6. 2008....
Mutation analysis of the NSD1 gene in patients with autism spectrum disorders and macrocephalyJoseph D Buxbaum
Laboratory of Molecular Neuropsychiatry, Mount Sinai School of Medicine, New York, USA
BMC Med Genet 8:68. 2007..Sotos syndrome has been described in a number of patients with autism spectrum disorders, suggesting that NSD1 could be involved in other cases of autism and macrocephaly...
Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled studyEric Hollander
Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
Int J Neuropsychopharmacol 6:397-401. 2003..Risperidone may be an effective and well-tolerated augmentation strategy in treatment-resistant OCD subjects, but larger sample size studies are required to demonstrate this...
Targeted treatments for symptom domains in child and adolescent autismEric Hollander
Seaver and New York Autism Center of Excellence, Mount Sinai School of Medicine, New York, NY 10029, USA
Lancet 362:732-4. 2003..Other symptom domains within autism and effects on development need to be evaluated in adequately designed clinical trials. Future strategies include extending treatment to children as young as the preschool years...
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorderEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 64:640-7. 2003....
Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disordersEric Hollander
Seaver and New York Autism Center of Excellence, Mount Sinai School of Medicine, New York, NY 10029, USA
Depress Anxiety 25:317-29. 2008..There are both advantages and disadvantages in creating a new diagnostic category in DSM-V, and these are discussed in this article...
Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disordersEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Neuropsychopharmacology 28:1186-97. 2003....
A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorderEric Hollander
Department, of Psychiatry, Box 1230, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, USA
World J Biol Psychiatry 4:30-4. 2003..Its effectiveness in specific subgroups of OCD patients with co-morbid anxiety disorders or as an augmentation strategy added to SSRIs remains to be determined...
Obsessive-compulsive behaviors in parents of multiplex autism familiesEric Hollander
Department of Psychiatry and Seaver Autism Research Center, Box 1230, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029 6574, USA
Psychiatry Res 117:11-6. 2003..Dichotomizing autistic probands by severity and type of repetitive behaviors (circumscribed interests and compulsive rituals) may yield more homogenous groups, which could be helpful in genetic linkage studies...
Striatal volume on magnetic resonance imaging and repetitive behaviors in autismEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, Annenberg Bldg, 1 Gustave L Levy Place, New York, NY 10029, USA
Biol Psychiatry 58:226-32. 2005....
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorderEric Hollander
Seaver and NY Autism Center of Excellence, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, New York 10029, USA
J Child Adolesc Psychopharmacol 16:541-8. 2006..Additional studies are needed to determine the efficacy and safety of olanzapine in the treatment of children with PDD...
Oxytocin increases retention of social cognition in autismEric Hollander
Mount Sinai School of Medicine, New York, New York, USA
Biol Psychiatry 61:498-503. 2007..This study explored the effect of intravenous oxytocin administration on the retention of social information in autism...
Pharmacological treatments of pathological gamblingEric Hollander
Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, Box 1230, One Gustave L Levy Place, New York, NY, USA
J Gambl Stud 21:99-110. 2005..This review focuses on recent research examining the treatment of pathological gambling and highlights methodological challenges for future studies...
Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorderEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, 1 Gustave L Levy Place, Box 1230, New York, NY 10029 6574, USA
Am J Psychiatry 162:621-4. 2005....
Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorderEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Int J Neuropsychopharmacol 9:209-13. 2006..616). This study provides preliminary support for the use of divalproex in treating repetitive behaviours in ASD. Further research is needed to evaluate the specificity and mechanism of action of these findings...
A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autismEric Hollander
Seaver and New York Autism Center of Excellence, New York, NY 10029, USA
Neuropsychopharmacology 30:582-9. 2005..Limitations include small sample size and the crossover design of the study. Further replication and long-term maintenance trials are needed...
Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorderEric Hollander
Mt Sinai School of Medicine, One Gustave Levy Place, Box 1230, NY, NY 10029, USA
J Neuropsychiatry Clin Neurosci 17:472-7. 2005..These subtle neurological abnormalities may implicate a potential subgroup of OCD patients with poorer treatment response. This may have treatment implications and therefore serve as a screening tool in OCD...
Beyond refractory obsessions and anxiety states: toward remissionEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 65:3-5. 2004..These and other issues should be discussed at future meetings of the IOCDC and influence how we conceptualize the disorder and design future treatment trials...
Impact of recent findings on study design of future autism clinical trialsEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York City, New York 10029 6574, USA
CNS Spectr 9:49-56. 2004..The Internet System for Assessing Autistic Children system for managing multicenter clinical trials in autism and statistical issues in autism research are also described...
Imaging monetary reward in pathological gamblersEric Hollander
Department of Psychiatry, Box 1230, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
World J Biol Psychiatry 6:113-20. 2005....
Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disordersEric Hollander
Department of Psychiatry, Seaver Autism Research Center, Mount Sinai School of Medicine, New York, NY 10029, USA
Neuropsychopharmacology 28:193-8. 2003..Repetitive behavior in autism spectrum disorders may be related to abnormalities in the oxytocin system, and may be partially ameliorated by synthetic oxytocin infusion...
An open trial of divalproex sodium in autism spectrum disordersE Hollander
Department of Psychiatry and Seaver Autism Research Center, Mt Sinai School of Medicine, New York, NY 10029 6574, USA
J Clin Psychiatry 62:530-4. 2001..Divalproex sodium is indicated as both an anticonvulsant in epilepsy and a mood stabilizer in bipolar illness and thus might be useful for these complicating symptoms in autism...
Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?Eric Hollander
Compulsive, Impulsive, and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Am J Psychiatry 162:137-45. 2005..To the authors' knowledge, this is the first placebo-controlled treatment study in pathological gamblers with bipolar spectrum disorders; it compares sustained-release lithium carbonate to placebo...
A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorderE Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
J Clin Psychiatry 62:199-203. 2001..Since anticonvulsant agents may be helpful in such symptomatology, we compared divalproex sodium with placebo in patients with borderline personality disorder...
Venlafaxine in treatment-resistant obsessive-compulsive disorderEric Hollander
Department of Psychiatry, Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 64:546-50. 2003..Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that might be effective in the treatment of OCD, even among those who have failed previous SSRI trials...
Pharmacotherapy for obsessive-compulsive disorderE Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
Psychiatr Clin North Am 23:643-56. 2000..Augmentation and monotherapy have been explored with serotonergic enhancers, dopamine and 5-HT antagonists, enhancers of second-messenger systems, and GABAergic agents with varying efficacy...
Refractory obsessive-compulsive disorder: state-of-the-art treatmentEric Hollander
Department of Psychiatry, Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 63:20-9. 2002..The authors synthesize state-of-the-art treatment and give practical advice for clinicians...
FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolismEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Neuropsychobiology 58:37-47. 2008..Although mood stabilizers and serotonin reuptake inhibitors have shown some efficacy in the treatment of this condition, there is little known about how these pharmacological interventions work...
Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetineEric Hollander
Department of Psychiatry, Box 1230, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029 6574, USA
J Clin Psychiatry 64:1113-21. 2003..This study evaluated the acute safety and efficacy and long-term efficacy, safety, and impact on relapse prevention of paroxetine in obsessive-compulsive disorder...
Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot studyM S Buchsbaum
Neiroscience PET Laboratory, Mt Sinai School of Medicine, New York, NY 10029 6574, USA
Int J Neuropsychopharmacol 4:119-25. 2001..These results are consistent with those in depression indicating that higher cingulate gyrus metabolic rates at baseline predict SRI response...
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gamblingJon E Grant
Department of Psychiatry, University of Minnesota Medical School, 2450 Riverside Avenue, Minneapolis, MN 55454, USA
Am J Psychiatry 163:303-12. 2006..The authors examined the efficacy and tolerability of the opioid antagonist nalmefene in the treatment of adults with pathological gambling...
Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imagingM M Haznedar
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
Am J Psychiatry 157:1994-2001. 2000....
Short-term single-blind fluvoxamine treatment of pathological gamblingE Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Am J Psychiatry 155:1781-3. 1998..The authors' goal was to assess the efficacy and tolerability of the selective serotonin reuptake inhibitor fluvoxamine in the treatment of pathological gambling...
Feeling unreal: a PET study of depersonalization disorderD Simeon
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Am J Psychiatry 157:1782-8. 2000..The goal of this study was to assess brain glucose metabolism and its relationship to dissociation measures and clinical symptoms in DSM-IV depersonalization disorder...
Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical reportE Hollander
Department of Psychiatry and the Seaver Autism Research Center, Mount Sinai School of Medicine, New York, New York 10029, USA
J Child Neurol 15:132-5. 2000..Controlled treatment trials with venlafaxine are warranted in autism spectrum disorders...
B lymphocyte antigen D8/17 and repetitive behaviors in autismE Hollander
Department of Psychiatry and the Seaver Autism Research Center, Mt Sinai School of Medicine, New York, NY 10029 6574, USA
Am J Psychiatry 156:317-20. 1999..The authors examined the rate of D8/17 expression in children with autism and its correlation with severity of repetitive behaviors...
Noradrenergic function in pathological gambling: blunted growth hormone response to clonidineS Pallanti
Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
J Psychopharmacol 24:847-53. 2010..This peripheral noradrenergic dysfunction could be consistent with attenuated cortico-frontal noradrenergic function as shown in positron emission tomography (PET) studies of PG...
Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phaseBernardo Dell'Osso
Department of Psychiatry, Compulsive and Impulsive Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 69:452-6. 2008..To assess the safety and efficacy of escitalopram in IC-IUD, we conducted a 10-week, open-label trial followed by a 9-week, double-blind, placebo-controlled discontinuation phase...
Comorbid social anxiety and body dysmorphic disorder: managing the complicated patientE Hollander
Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 60:27-31. 1999..Additionally, depression and suicide are frequent complications of BDD. Pharmacologic and nonpharmacologic treatments for the management of BDD with coexisting social anxiety are presented in this article...
Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorderS J Mathew
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York, USA
Depress Anxiety 14:199-208. 2001..The limitations of IV CMI as a specific probe of serotonin function are discussed...
Lithium and valproate treatment of pathological gambling: a randomized single-blind studyStefano Pallanti
Mount Sinai School of Medicine, New York, NY, USA
J Clin Psychiatry 63:559-64. 2002..The aim of the present study was to evaluate the efficacy and safety of lithium and valproate in nonbipolar pathological gamblers...
Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography studyStefano Pallanti
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
Neuropsychobiology 62:132-8. 2010..We extended our studies to include functional alterations of the striatum and thalamus in a cohort of patients with PG before and after treatment with lithium...
Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disordersEric Hollander
Department of Psychiatry, Montefiore Medical Center University Hospital for Albert Einstein College of Medicine, Child Psychiatry Annex, Bronx, NY 10467 2490, USA
Neuropsychopharmacology 35:990-8. 2010..This study suggests the efficacy of divalproex for the treatment of irritability in children and adolescents with ASD. Larger sample follow-up studies are warranted...
Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depressionMadhukar H Trivedi
Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, TX 75235, USA
J Clin Psychiatry 69:246-58. 2008..This article reviews research on the current understanding and management of residual symptoms, i.e., subthreshold depressive symptoms present after recovery from a major depressive episode...
Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorderEric Hollander
Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, New York 10029, USA
Int Clin Psychopharmacol 21:189-91. 2006..Our case suggests that topiramate might be beneficial in augmentation with selective serotonin reuptake inhibitors in patients with treatment-resistant OCD, although further investigations are warranted to confirm our findings...
Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical reviewGerald Nestadt
Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 67:600-10. 2006..Double-blind, placebo-controlled studies are, however, needed to confirm the positive findings reported by several studies with venlafaxine...
Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical responseS Pallanti
Department of Psychiatry, Mount Sinai School of Medicine, Bronx, New York, NY, USA
Neuropsychobiology 65:227-35. 2012..We investigated the clinical, cognitive and neurophysiologic effects of a 3 weeks' protocol of low-frequency rTMS applied over the right DLPFC in resistant depression...
Oxytocin administration attenuates stress reactivity in borderline personality disorder: a pilot studyD Simeon
Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine and Beth Israel Medical Center, 317 East 17th Street, New York, NY, USA
Psychoneuroendocrinology 36:1418-21. 2011..013). Results suggest that oxytocin may have a beneficial impact on emotional regulation in BPD, which merits further investigation and could have important treatment implications...
Body dysmorphic disorderA Allen
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
Psychiatr Clin North Am 23:617-28. 2000..Investigations in brain imaging and genetics are underway. Research in pharmacotherapy and CBT, individually and combined, is needed to refine, extend, and optimize treatment...
Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneityJ D Buxbaum
Laboratory of Molecular Neuropsychiatry, Mount Sinai School of Medicine, New York, NY, 10029, USA
Am J Hum Genet 68:1514-20. 2001....
Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS)Stefano Pallanti
Mount Sinai School of Medicine, New York, NY 10029, USA
J Gambl Stud 21:431-43. 2005..PG-YBOCS thus appears to be a reliable and valid measure of pathological gambling severity, and can be regarded as an important tool for clinicians and researchers treating pathological gamblers...
Lack of evidence for association of the serotonin transporter gene SLC6A4 with autismNicolas Ramoz
Laboratory of Molecular Neuropsychiatry, Department of Psychiatry, Seaver Autism Research Center, Mount Sinai School of Medicine, New York, New York 10029, USA
Biol Psychiatry 60:186-91. 2006..Specific variants of the 5-HTT gene, SLC6A4, especially the insertion-deletion 5-HTTLPR promoter locus, have been found to modulate its expression and transporter function...
Predicting response to opiate antagonists and placebo in the treatment of pathological gamblingJon E Grant
Department of Psychiatry, University of Minnesota School of Medicine, 2450 Riverside Avenue, Minneapolis, MN 55454, USA
Psychopharmacology (Berl) 200:521-7. 2008..No studies have systematically examined predictors of medication treatment outcome in PG. Understanding clinical variables related to treatment outcome should help generate treatment algorithms for PG...
Oxytocin and experimental therapeutics in autism spectrum disordersJennifer A Bartz
Mount Sinai School of Medicine, New York, NY, USA
Prog Brain Res 170:451-62. 2008..Finally, we conclude with a discussion of directions for future research...
Nefazodone treatment of pathological gambling: a prospective open-label controlled trialStefano Pallanti
Department of Psychiatry, Mount Sinai School of Medicine, New York, N.Y, USA
J Clin Psychiatry 63:1034-9. 2002..Side effects (dry mouth and sedation) of moderate severity occurred in 4 subjects. CONCLUSION: These preliminary results suggest that nefazodone may be effective in reducing symptoms of pathological gambling and is well tolerated...
The impact of comorbidity on the management of pathological gamblingEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
CNS Spectr 10:619-21. 2005..The identification of specific subtypes among patients with pathological gambling may be relevant to the choice of pharmacologic treatment...
WCA recommendations for the long-term treatment of generalized anxiety disorderChrister Allgulander
Department of Psychiatry, Harvard University School of Medicine, Boston, Massachusetts, USA
CNS Spectr 8:53-61. 2003..Treatment gains after a 12-week course of CBT may be maintained for up to 1 year. Currently, no guidelines exist for the long-term treatment of GAD...
ImpulsivityE Hollander
Department of Psychiatry and the Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
J Psychopharmacol 14:S39-44. 2000....
An open-label trial of divalproex extended-release in the treatment of borderline personality disorderDaphne Simeon
Department of Psychiatry, The Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
CNS Spectr 12:439-43. 2007..Divalproex extended-release (ER) is used widely in clinical practice, which leads to the question of its efficacy and tolerability in treating BPD...
Psychopharmacologic interventions for repetitive behaviors in autism spectrum disordersLatha Soorya
Department of Psychiatry, Seaver and New York Autism Center of Excellence, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
Child Adolesc Psychiatr Clin N Am 17:753-71, viii. 2008..To date, data are mixed for interventions commonly prescribed in clinical practice and suggest several areas of investigation in advancing research on the medication management of repetitive behaviors...
Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developmentsHeather A Berlin
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
Mt Sinai J Med 75:174-203. 2008....
Impulsive-compulsive sexual behaviorThomas M Mick
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
CNS Spectr 11:944-55. 2006..The data regarding this disorder and its overlap with chemical addiction is limited. If the two disorders are to be grouped together, further data are needed...
An open-label trial of venlafaxine in body dysmorphic disorderAndrea Allen
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
CNS Spectr 13:138-44. 2008..This open-label trial examines venlafaxine's efficacy in BDD and is the first known study of this serotonin-norepinephrine reuptake inhibitor in BDD...
A review of pharmacologic treatments for obsessive-compulsive disorderAlicia Kaplan
Department of Psychiatry, Mount Sinai Scjhool of Medicine, New York, New York 10029, USA
Psychiatr Serv 54:1111-8. 2003..In this article the authors review studies of pharmacologic treatments...
Peritraumatic reactions associated with the World Trade Center disasterDaphne Simeon
Psychiatry Box 1229, Mt Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
Am J Psychiatry 160:1702-5. 2003..The World Trade Center disaster was of unprecedented magnitude and impact in U.S. history. The authors conducted a pilot survey investigating these effects...
Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephalyJoseph D Buxbaum
Laboratory of Molecular Neuropsychiatry, Mount Sinai School of Medicine, New York, New York, USA
Am J Med Genet B Neuropsychiatr Genet 144:484-91. 2007..Screening of PTEN mutations is warranted in patients with autism and pronounced macrocephaly, even in the absence of other features of PTEN-related tumor syndromes...
Comprehensive treatment of three patients with comorbid OCPD and ADHDStephen C Josephson
Cornell University Medical School, New York, NY, USA
CNS Spectr 12:338-42. 2007..Significant symptom reduction was observed as a result of this combined intervention...
Obsessive-compulsive disorder spectrum as a scientific "metaphor"Stefano Pallanti
Strategic Center of Excellence of Psychiatry, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
CNS Spectr 13:6-15. 2008..By increasing research in this field, the OCD spectrum may evolve from a fragmented level of conceptualization as a "metaphor" to one that is more comprehensive and structured...
The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behaviorJennifer A Bartz
Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
Horm Behav 50:518-28. 2006..Finally, unresolved issues and directions for future research are discussed...
Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnessesM Mehmet Haznedar
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029 6574, USA
Biol Psychiatry 57:733-42. 2005....
Dissociation and posttraumatic stress 1 year after the World Trade Center disaster: follow-up of a longitudinal surveyDaphne Simeon
Mount Sinai School of Medicine, Department of Psychiatry, New York, NY 10029, USA
J Clin Psychiatry 66:231-7. 2005..We conducted a 1-year follow-up of an original mail survey of early reactions to the World Trade Center disaster...
Bipolar disorder and comorbid attention deficit hyperactivity disorder. A distinct clinical phenotype? Clinical characteristics and temperamental traitsSilvia Bernardi
Department of Psychiatry, Mount Sinai School of Medicine, New York 10029, USA
World J Biol Psychiatry 11:656-66. 2010..We further hypothesize that maladaptive temperament will be associated with the severity of both illnesses...
Relationship between whole blood serotonin and repetitive behaviors in autismAlexander Kolevzon
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Psychiatry Res 175:274-6. 2010..No significant associations were found between serotonin level and the primary behavioral outcome measures. However, a significant inverse relationship between serotonin level and self-injury was demonstrated...
Is obsessive-compulsive disorder an anxiety disorder?Jennifer A Bartz
Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
Prog Neuropsychopharmacol Biol Psychiatry 30:338-52. 2006..The implications of removing OCD from the anxiety disorders category and moving it to an OC spectrum disorders category, as is being proposed for the DSM-V, is discussed...
Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerabilityAlexander Kolevzon
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
J Clin Psychiatry 67:407-14. 2006..This article reviews the available data on the efficacy and tolerability of SSRIs in individuals with autism spectrum disorders. Objectives for future research in this area will also be suggested...
Symptom domains in autism and related conditions: evidence for familialityJeremy M Silverman
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
Am J Med Genet 114:64-73. 2002..Making distinctions among families by the severity of these features may be useful for identifying more genetically homogeneous subgroups in studies targeted at genes for specific autism-related symptom domains...
Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patientsMonte S Buchsbaum
Mount Sinai School of Medicine, New York, NY 10029, USA
Neuropsychobiology 53:157-68. 2006..Our results are consistent with a frontostriatal circuit change related to both dopaminergic and serotonergic systems and with the presence of psychopharmacological subtypes within OCD...
The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity studySuck Won Kim
Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN 55454, USA
Psychiatry Res 166:76-84. 2009..The correlations between the G-SAS and the PG-YBOCS and Clinical Global Impression rating were excellent. Findings suggest that the G-SAS is reliable and valid in assessing changes in symptoms during a drug treatment study...
Autism-related routines and rituals associated with a mitochondrial aspartate/glutamate carrier SLC25A12 polymorphismJeremy M Silverman
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
Am J Med Genet B Neuropsychiatr Genet 147:408-10. 2008..No other significant differences were observed. The rs2056202 polymorphism may be associated with levels of routines and rituals in autism and related disorders...
Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disordersM Mehmet Haznedar
Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1505, New York, NY 10029, USA
Am J Psychiatry 163:1252-63. 2006..The authors used imaging studies to map volumetric and metabolic differences within the entire dorsoventral extent of the striatum and thalamus...
Diagnosis and treatment of body dysmorphic disorder in adolescentsSallie Jo Hadley
Mount Sinai Medical Center, Department of Psychiatry, Box 1230, New York, NY 10029, USA
Curr Psychiatry Rep 4:108-13. 2002....
Epidemiologic and clinical updates on impulse control disorders: a critical reviewBernardo Dell'Osso
Compulsive, Impulsive and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
Eur Arch Psychiatry Clin Neurosci 256:464-75. 2006..Particular attention is paid to the relationship between ICDs and obsessive-compulsive disorder (OCD). Finally, current pharmacological options for treating ICDs are presented and discussed...
Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective studyStefano Pallanti
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
CNS Drugs 23:1047-55. 2009..Trial registration number (ClinicalTrials.gov): NCT00796497...
Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directionsBernardo Dell'Osso
Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
CNS Spectr 10:966-79, 983. 2005..Nevertheless, promising findings regarding efficacy, tolerability, and non-invasiveness and/or reversibility of these techniques have increased interest in investigating their use in treatment-resistant OCD...
Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled studyStacey Wasserman
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Int Clin Psychopharmacol 21:363-7. 2006..These findings suggest that levetiracetam does not improve behavioral disturbances of autism, but are limited by the small sample size and lack of stratification of the autistic sample at baseline...
Regional glucose metabolism within cortical Brodmann areas in healthy individuals and autistic patientsErin A Hazlett
Department of Psychiatry, Mount Sinai School of Medicine, New York, N Y, USA
Neuropsychobiology 49:115-25. 2004..Patients failed to show these patterns. Autism patients have dysfunction in some but not all of the key brain regions subserving verbal memory performance, and other regions may be recruited for task performance...
Relationship of personality to dissociation and childhood trauma in borderline personality disorderDaphne Simeon
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
CNS Spectr 8:755-62. 2003..The purpose of this study was to investigate the relationship between dissociation and childhood trauma in BPD and to explore the relationships of dissociation and trauma to various personality features of BPD...
A preliminary study of cortisol and norepinephrine reactivity to psychosocial stress in borderline personality disorder with high and low dissociationDaphne Simeon
Department of Psychiatry, Mount Sinai School of Medicine, Psychiatry Box 1230, One Gustave L Levy Place, New York, NY 10029, USA
Psychiatry Res 149:177-84. 2007..In conclusion, despite its small sample size this pilot study suggests that dissociative symptomatology may be a marker of heightened biological vulnerability to stress in BPD, and merits further study...
Linkage analysis for autism in a subset families with obsessive-compulsive behaviors: evidence for an autism susceptibility gene on chromosome 1 and further support for susceptibility genes on chromosome 6 and 19J D Buxbaum
Laboratory of Molecular Neuropsychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Mol Psychiatry 9:144-50. 2004..The data suggest that there is an autism susceptibility gene on chromosome 1 and provide further support for the presence of autism susceptibility genes on chromosomes 6 and 19...
Dermatology and conditions related to obsessive-compulsive disorderD J Stein
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032
J Am Acad Dermatol 26:237-42. 1992..Many of these disorders, which include trichotillomania, neurotic excoriation, onychophagia, body dysmorphic disorder, and dermatitis artefacta may respond to specific therapeutic interventions...
Diagnosis and treatment of obsessive-compulsive disorder and related disordersB Dell'Osso
Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY, USA
Int J Clin Pract 61:98-104. 2007....
Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorderD Simeon
Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
Neuropsychopharmacology 25:793-5. 2001..The purpose of this preliminary study was to investigate HPA axis function in dissociation...
Heat shock protein 90 antibodies in autismM Evers
Department of Psychiatry, Seaver Autism Research Center, Mt Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029-6574, USA
Mol Psychiatry 7:S26-8. 2002
A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorderStefano Pallanti
Department of Psychiatry, University of Florence, Italy
J Clin Psychiatry 65:6-10. 2004..More results are needed before the effectiveness of the nonpharmacologic treatments for OCD can be determined...
WCA Recommendations for the long-term treatment of posttraumatic stress disorderDan J Stein
Medical Research Council Research Unit on Anxiety Disorder, University of Stellenbosch, Cape Town, Tygerberg, South Africa
CNS Spectr 8:31-9. 2003..Only SSRIs have been proven effective and safe in long-term randomized controlled trials. Current guidelines from the Expert Consensus Panel for PTSD recommend treatment of chronic PTSD for a minimum of 12-24 months...
Practice guideline for the treatment of patients with obsessive-compulsive disorderLorrin M Koran
Am J Psychiatry 164:5-53. 2007
WCA recommendations for the long-term treatment of social phobiaMichael Van Ameringen
Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
CNS Spectr 8:40-52. 2003..In light of the chronicity and disability associated with social phobia, as well as the high relapse rate after short-term therapy, it is recommended that effective treatment be continued for at least 12 months...
Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorderEvdokia Anagnostou
J Clin Psychopharmacol 26:444-6. 2006
WCA recommendations for the long-term treatment of panic disorderMark H Pollack
Division of Psychiatry, Huddinge University Hospital, Stockholm, Sweden
CNS Spectr 8:17-30. 2003..Long-term efficacy and ease of use are important considerations in treatment selection, as maintenance treatment is recommended for at least 12-24 months, and in some cases, indefinitely...
Social anxiety in outpatients with schizophrenia: a relevant cause of disabilityStefano Pallanti
Department of Neurological and Psychiatric Sciences, University of Florence, Italy
Am J Psychiatry 161:53-8. 2004....
WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adultsJohn H Greist
Healthcare Technology Systems, Inc, Madison, Wisconsin 53717, USA
CNS Spectr 8:7-16. 2003..Further, pharmacotherapy for a minimum of 1-2 years is recommended before very gradual withdrawal may be considered...
Research Grants
- FLUOXETINE IN PEDIATRIC BODY DYSMORPHIC DISORDEREric Hollander; Fiscal Year: 2006..Abstract Not Provided. ..
- Greater New York Autism Research Center of ExcellenceJoseph Buxbaum; Fiscal Year: 2007..Core B: Clinical Core; Core C: Data Management and Statistics Core; Core D: Information Transfer Core. ..
- Training in Psychopharmacology and Outcomes ResearchRonald Rieder; Fiscal Year: 2007..Stipends are requested to support the entry of two fellows per year for the initial two years and then three fellows per year for up to three years of training. ..
- Divalproex Sodium/Placebo In Child/Adolesent AutismEric Hollander; Fiscal Year: 2003....
- PHARMACOTHERAPY OF ADOLESCENT BODY DYSMORPHIC DISORDEREric Hollander; Fiscal Year: 2002..When untreated, adolescent-onset BDD appears to often interfere with the developmental tasks of adolescence, to persist, and to cause substantial morbidity through out the life span. ..
